Lam Research (LRCX): CFO sold ~$6.04M

~$6.04M

Approx. value · 40K sh @ $150.60

987K

Holds after · shares reported

Traded

Nov 14, 2025

Filed

Nov 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 13, 2025CongressDisclosed purchase of LRCX — reported range $1,001 - $15,000
2. Sep 3, 2025CongressDisclosed sale of LRCX — reported range $1,001 - $15,000
3. Sep 22, 2025Congress · 1 personMembers of Congress: 2 sales
4. Sep 23, 2025CongressDisclosed sale of LRCX — reported range $1,001 - $15,000
5. Oct 13, 2025Insider · Their largest sale since 2019Officer sold ~$7.25M of LRCX shares in the open market
6. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
7. Oct 27, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
8. Nov 3, 2025InsiderDirector sold ~$208K of LRCX shares in the open market
9. Nov 4, 2025Company filing · Form 8-K · Shareholder rights, Executive changeChanged a top executive or board member, and changed the rights of its shareholders (and 2 more items)
10. Nov 7, 2025InsiderDirector sold ~$4.8K of LRCX shares in the open market
11. Nov 14, 2025 · this disclosureInsiderCFO sold ~$6.04M of LRCX shares in the open market

What came next

1. Nov 20, 2025Government · Federal Register noticePhasedown of Hydrofluorocarbons: Notice of 2026 Allowance Allocations for Production and Consumption of Regulated Substances Under the American Innovation and Manufacturing Act of 2020, and Notice of Final Actions Establishing Administrative Consequences
2. Dec 17, 2025Insider · 1 personInsiders: 2 sales (~$26.8M)
3. Dec 29, 2025CongressDisclosed purchase of LRCX — reported range $50,001 - $100,000
4. Jan 8, 2026Congress · 2 peopleMembers of Congress: 3 sales
5. Jan 16, 2026CongressDisclosed sale of LRCX — reported range $1,001 - $15,000
6. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
7. Jan 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 3, 2026, the Board of Directors (the “Board”) of Lam Research Corporation (the “Company”), pursuant to applicable provisions of the Company’s Amended and Restated Bylaws, appointed Anirudh Devgan, Ph.D., age 56, as a director of the Company, effective immediately.”
8. Jan 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 3, 2026, Lam Research Corporation (the “Company”) filed a Current Report on Form 8-K (the “Initial Form 8-K”) wherein it reported that it had issued a press release (the “Exhibit 99.2 Press Release”) announcing the retirement of Patrick J. Lord, Ph.D. and the appointment of Seshasayee (Sesha) Varadarajan as the Company’s executive vice president and chief operating officer.”
9. Feb 3, 2026CongressDisclosed purchase of LRCX — reported range $15,001 - $50,000
10. Feb 6, 2026Insider · 1 personInsiders: 2 sales (~$7.9M)
11. Feb 26, 2026Congress · 1 personMembers of Congress: 2 sales
12. Mar 2, 2026Insider · 2 peopleInsiders: 2 sales (~$10.2M)
13. Mar 4, 2026Insider · 2 peopleInsiders: 2 sales (~$11.5M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lam Research

For Lam Research, OQRO holds 12 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 97 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LRCX page.

Other recent filings by Douglas R Bettinger, Chief Financial Officer & EVP

• SEC Form 4 at Lam Research (LRCX)Mar 5, 2026
• SEC Form 4 at Lam Research (LRCX)Mar 3, 2026

The full history of Douglas R Bettinger, Chief Financial Officer & EVP is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Lam Research

• House Clerk periodic transaction reportOct 29, 2026
• SEC Form 4Oct 26, 2026
• SEC Form 144Oct 23, 2026
• SEC Form 4Sep 10, 2026
• SEC Form 4Sep 10, 2026
• SEC Form 144Sep 9, 2026

Everything OQRO holds on this company is on its LRCX page.